An Analysis of the Quality of Life and Sexual Quality of Life of Cervical Cancer Radiotherapy Patients
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03885505 |
Recruitment Status :
Not yet recruiting
First Posted : March 21, 2019
Last Update Posted : June 25, 2019
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Cervical Cancer Radiotherapy Side Effect Quality of Life |
Objective: To investigate the quality of life and sexual quality of life and its influencing factors in cervical cancer undergoing radiotherapy patients.
Methods:The cervical cancer cancer scale (FACT-Cx4.0) and the female sexual function index (FSFI) in the cancer treatment function evaluation system were used. The quality of life and sexual quality of life of cervical cancer patients undergoing radiotherapy in PUMC Hospital were analyzed and scored to analyze the effects of age, education level, clinical stage and treatment methods on the quality of life and sexual quality of life of cervical cancer radiotherapy patients
Study Type : | Observational |
Estimated Enrollment : | 200 participants |
Observational Model: | Other |
Time Perspective: | Retrospective |
Official Title: | An Analysis of the Quality of Life and Sexual Quality of Life of Cervical Cancer Radiotherapy Patients |
Estimated Study Start Date : | June 25, 2019 |
Estimated Primary Completion Date : | August 1, 2019 |
Estimated Study Completion Date : | September 1, 2019 |

- using fact-cx4.0 to evaluate the qol of cervical cancer patients undergoing radiotherapy [ Time Frame: through study completion, an average of half a year ]
Functional Assessment of Cancer Therapy-Cervix V4.0 (FACT-Cx V4.0) was used to evaluate patients'quality of life. The scale is composed of general cancer quality of life assessment scale (FACT-G) and cervical cancer specific module (CCS). It contains 5 dimensions and 42 subjects. The higher the score of positive questions, the better the quality of life. The higher the score of reverse questions, the worse the quality of life. If it is a reverse question, the original score of this question is subtracted by 4. The higher the total score, the better the quality of life. The study was conducted by face-to-face investigation of specialist nurses. All patients'investigation data were kept strictly confidential.
And follow the principles of medical ethics.using spss to analysis the data.
- using fsfi to evaluate the qol of cervical cancer patients undergoing radiotherapy [ Time Frame: through study completion, an average of half a year ]Female Sexual Function Index (FSFI) was used to measure the quality of sexual life. The higher the score of positive items, the worse the quality of sexual life. If the reverse items were negative, the original score of the item could be subtracted by 5. The higher the total score, the better the quality of sexual life. The study was conducted by face-to-face investigation by specialist nurses. All patients'investigation data were strictly confidential and followed the medical ethics principles.using spss to analysis the data.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 80 Years (Adult, Older Adult) |
Sexes Eligible for Study: | Female |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- adult female
- diagnosed with cervical cancer' and acquire therapy as part of treatment
- undertaken or have finished radiotherapy in Peking Union Medical College Hospital
- agreed with informed consent
Exclusion Criteria:
- with cognitive dysfunction or cannot fulfilled the questionaire
- refuse or quit the research
- submit questionnaire with missing information
Responsible Party: | HONGNAN ZHEN, department of radiation oncology, Peking Union Medical College Hospital |
ClinicalTrials.gov Identifier: | NCT03885505 |
Other Study ID Numbers: |
ZHN 20181125 |
First Posted: | March 21, 2019 Key Record Dates |
Last Update Posted: | June 25, 2019 |
Last Verified: | June 2019 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | Undecided |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Uterine Cervical Neoplasms Uterine Neoplasms Genital Neoplasms, Female Urogenital Neoplasms |
Neoplasms by Site Neoplasms Uterine Cervical Diseases Uterine Diseases |